New York City, NY – According to filings with the U.S. Securities and Exchange Commission, TMRW Life Sciences is raising $36,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Joshua Abram played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About TMRW Life Sciences

The TMRW platform revolutionizes the management, identification, and storage of fertility cells replacing the error-prone manual and analog methods that have remained largely unchanged since IVF was first used in animal husbandry more than fifty years ago. Developed in partnership with leading fertility doctors and embryologists, TMRW’s technology significantly reduces the risk of loss or misidentification of the precious cells used in IVF. TMRW’s technology will play a central role in the conception of tens of millions of people in the coming years.

To learn more about TMRW Life Sciences, visit http://www.tmrw.org/

Contact:
Joshua Abram, Chief Executive Officer
917-525-3453
joshua@tmrw.org
https://www.linkedin.com/in/joshuaabram/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved